Purchases and Sales Made in Q2 2024 in Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE) during Q2 2024. The information is specifically focused on institutions that hold shares of Xenon Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-47.7K- 59.65% |
$1.73M - $2.09M
|
32.3K
$1.24M
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-65.7K- 4.53% |
$2.38M - $2.87M
|
1.38M
$53M
|
|
|
Aug 14, 2024
Q2 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-67.9K- 28.41% |
$2.46M - $2.97M
|
171K
$6.56M
|
|
|
Aug 14, 2024
Q2 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-76.1K- 2.91% |
$2.76M - $3.33M
|
2.54M
$97.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-79.5K- 28.95% |
$2.88M - $3.48M
|
195K
$7.48M
|
|
|
Aug 13, 2024
Q2 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-93.8K- 2.39% |
$3.4M - $4.11M
|
3.83M
$147M
|
|
|
Aug 14, 2024
Q2 2024
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-106K- 50.85% |
$3.82M - $4.62M
|
102K
$3.91M
|
|
|
Jul 18, 2024
Q2 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-113K- 60.56% |
$4.1M - $4.94M
|
73.6K
$2.82M
|
|
|
Aug 14, 2024
Q2 2024
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-140K- 45.25% |
$5.08M - $6.13M
|
169K
$6.49M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-147K- 38.17% |
$5.34M - $6.45M
|
239K
$9.15M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-147K- 38.17% |
$5.34M - $6.45M
|
239K
$9.15M
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-183K- 17.41% |
$6.62M - $7.99M
|
867K
$33.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-309K- 34.63% |
$11.2M - $13.5M
|
583K
$22.3M
|
|
|
Aug 07, 2024
Q2 2024
|
First Turn Management, LLC
Del Mar, CA |
SELL
|
- |
-341K- 50.05% |
$12.3M - $14.9M
|
340K
$13M
|
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-442K- 17.77% |
$16M - $19.3M
|
2.04M
$78.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-518K- 40.27% |
$18.8M - $22.7M
|
769K
$29.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-705K- 78.77% |
$25.6M - $30.9M
|
190K
$7.28M
|
|
|
Oct 07, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-705K- 78.77% |
$25.6M - $30.9M
|
190K
$7.28M
|